Company: SION
Filing Date: 2025-03-20
Form Type: 8-K
Source: 0001193125-25-058306
Chunk: 1

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-03-20
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  99.1      Press Release of Sionna Therapeutics, Inc. dated March 20, 2025.              
 ──────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        Sionna Therapeutics, Inc.               
  Date: March 20, 2025      By:         /s/ Jennifer Fitzpatrick                
                            Name:       Jennifer Fitzpatrick                    
                            Title:      Senior Vice President, General Counsel